AYTU financials

Aytu BioPharma (AYTU) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

AYTU income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2026$57.57M$36.82M-$8.31M-$14.25M-1.16
2025$66.38M$45.83M-$7.83M-$13.56M-2.16
2024$65.18M$49.05M-$1.59M-$15.84M-2.86
2023$107.40M$66.63M-$17.07M-$17.05M-5.11
2022$96.67M$52.28M-$109.91M-$108.78M-74.01
2021$65.63M$29.20M-$58.87M-$58.29M-69.60